New Urine-Based Assay Helps Determine Need for Repeat Biopsy

Share this content:

A newly approved prostate cancer gene 3 assay may help determine the need for repeat prostate biopsies in men who have had a previous negative biopsy. John Schieszer reports in today's Medical Minute the new urine-based molecular test may help fill an important unmet clinical need.
You must be a registered member of Renal and Urology News to post a comment.

Sign Up for Free e-newsletters